NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026

Go back to NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
(NASDAQ: NKGN) Delayed: 0.19 --0 (-0%)
Previous Close $0.19    52 Week High
Open $0.19    52 Week Low
Day High $0.19    P/E N/A 
Day Low $0.19    EPS
Volume 48,244